HomeEXECUTIVES
EXECUTIVES
The medical device news magazine is the latest source for industry scoop. In this article, we take a look at which executives are on the move.
As the medical device industry rapidly expands, so does the need for executive leadership. Recently, several top executives have made moves within the industry. Some have taken new positions at other companies, while others have started their own businesses. Here’s a look at who’s been making headlines lately.
Crossject Appoints Tony Tipton as U.S. Chief Operating Officer in Preparation for Commercialization of ZEPIZURE® Epilepsy Rescue Treatment
Tony Tipton has over 25 years of experience across the key pillars of commercial pharmaceuticals business, encompassing corporate leadership, business development, market access, sales force leadership, marketing and trade operations.
Dr Kali Stasi Appointed Chief Medical Officer at SalioGen Therapeutics
Most recently, Dr Kali Stasi served as Senior Vice President of Clinical Development at Adverum Biotechnologies.
Lloyd Diamond | Appointed Chief Executive Officer at Nitinotes
Lloyd Diamond brings more than 30 years of leadership in the medical device industry, having spearheaded significant advancements in orthopedics, endoscopic, and general surgical devices. Most recently, he served as CEO of Pixium Vision S.A., where he led the development of groundbreaking bionic vision systems and strategic partnerships.
restor3d Expands Healthcare Innovation | Welcomes New Robotics and Navigation Experts
“We welcome the addition of Larry Hazbun, Senior Vice President of Robotics and Kirstin Widding, Senior Vice President of Hip & Knee.” Said Ken Gall, restor3d Chief Commercial Officer and Co-Founder. “The addition of robotics and navigation technologies is a natural fit with personalization and a perfect compliment to our patient specific implants. By integrating these enabling technologies with our existing 3D-printed patient specific implants and instruments, restor3d is poised to offer a more holistic approach to personalized patient treatment.”
Kevin McGowan Hired at Chemify as Chief Business Officer to Scale Commercial and Business Growth of Digital Chemistry Technology
As an expert in pharmaceutical business development, platform technology strategy, sales and marketing, Kevin McGowan will help Chemify scale its commercialization and operations and further expand into U.S. markets.
Paragon 28 Appoints Chadi Chahine
Chadi Chahine has been appointed Chief Financial Officer and Executive Vice-President of Supply Chain Operations, effective August 5, 2024. The Company also reported financial results for the quarter ended June 30, 2024, and narrowed its 2024 net revenue guidance.
José Trevejo M.D. Ph.D Appointed Chief Medical Office at Enveda Biosciences
Dr. José Trevejo joins Enveda following a string of recent successes, most recently at Tarsus Pharmaceuticals, where he helped lead the FDA approval and launch of a novel category-creating ophthalmic treatment along with multiple positive Phase 2 readouts. He brings more than fifteen years of leadership and drug development expertise to Enveda, spanning the entire clinical development process from proof-of-concept through approval and early commercialization.
Dr Robert Alexander Joins T3D Therapeutics’ Scientific Advisory Board
Alzheimer's disease expert Dr Robert Alexander will help shape the future development path of T3D Therapeutics' lead drug candidate T3D-959 as a potential disease remedial therapy for Alzheimer's patients.
Doug Cassidy Appointed President of the Deep 6 AI Precision Research Ecosystem, the Largest Network of Sites and Sponsors Using AI To Accelerate Research
"Doug Cassidy, formerly our SVP and GM of healthcare organizations, has led the growth of our Ecosystem—from the first site, Cedars-Sinai in 2017, to the launch of our life sciences vertical in 2021, to now," said Wout Brusselaers, founder and CEO of Deep 6 AI. "With over 25 years of diversified experience exclusively in the healthcare IT and clinical research technology sectors, Cassidy is poised to take on an expanded role as president of the Deep 6 AI Precision Research Ecosystem to drive its continued growth and improve collaboration between sites and sponsors."
